Abstract
Purpose: Gastric bypass patients, especially those with malabsorptive procedures, often have profound 25-hydroxy vitamin D (Vit D) deficiency with secondary elevation of parathyroid hormone (PTH) levels causing accelerated bone loss. Hypocalcaemia has developed in such patients receiving antiresorptive therapy (e.g. bisphosphonates). Vit D supplementation decreases PTH gene transcription via the Vit D receptor, similar effects are seen via the calcium receptor with high dose calcium replacement. We hypothesized that treating these patients with high dose Vit D and calcium could reverse secondary hyperparathyroidism (SecHPT).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
